Medication
Hydromorphone Hydrochloride Injection Usp
DIN 02145901 · Sandoz Canada Incorporated Likely a generic
What it is
- Active ingredients
- Hydromorphone Hydrochloride — 2 mg
- Form and routes
- Solution · Subcutaneous, Intramuscular, Intravenous
- Schedule
- NARCOTICS (CDSA I)
- Authorised since
- 1995-12-31
Source: Health Canada — Drug Product Database. Data current as of 2026-08-12.
Products with the same active ingredient
- Dilaudid
- PMS-Hydromorphone Tab 2MG
- Apo-Hydromorphone
- Hydromorphone Hydrochloride Injection
- Hydromorphone Hydrochloride Injection, Usp
Grouped by Health Canada’s active-ingredient group number. Products in a group do not always share a strength — check the strength above against your own. Sharing an active ingredient does not mean two products can be substituted for each other: whether a substitution is permitted is a provincial decision, and this page does not show it. Ask a pharmacist.
Watch this medication
Ontario Drug Benefit coverage
As of 31 July 2026General benefit Part III-A
Ontario lists this product as a general benefit under the Ontario Drug Benefit program — Part III-A of the Formulary/CDI. For someone eligible for ODB, it is covered without a drug-specific approval.
- What ODB pays per unit
- $1.7830
This is what the Ontario Drug Benefit program reimburses a pharmacy for one unit, as of 31 July 2026. A deductible and a co-payment sit on top of it and differ by program — ODB, the Trillium Drug Program and the seniors co-payment each work differently — so it is not the figure anyone is charged at a counter. It also says nothing about private, workplace or federal coverage.
Source: Ontario Ministry of Health — ODB Formulary. Data current as of 2026-07-28. Ontario only. Formulary edition 4342, effective 31 July 2026.
How it is classified
- Anatomical main group
- Nervous system
- ATC code
- N02AA03
The Anatomical Therapeutic Chemical code records the body system a medicine acts on and its chemical grouping. It is not a statement of what this medication treats, and nothing on this page is. For the full classification of N02AA03, see the WHO ATC/DDD Index.
Recalls and safety alerts
As of 12 August 2026Possible matches
These notices name a product name that more than one company sells. They may or may not concern this manufacturer’s product — Health Canada’s data does not say. They are not recalls of this product.
Hydromorphone hydrochloride injection USP (2018-01-31)
Possible match. This notice names “HYDROMORPHONE HYDROCHLORIDE INJECTION USP”, and 7 authorised products from 3 companies are sold under that name. The notice does not say which of them is affected.
Archived by Health Canada
1 older notice naming this product has been archived. These are a record of what happened, not current warnings.
Hydromorphone Hydrochloride Injection USP HP 10 (2017-07-26)
Possible match. This notice names “HYDROMORPHONE HYDROCHLORIDE INJECTION USP”, and 7 authorised products from 3 companies are sold under that name. The notice does not say which of them is affected.
This list may be incomplete. Health Canada’s recalls data carries no DIN, so notices are matched on wording alone. Search Health Canada recalls for Hydromorphone Hydrochloride Injection Usp → How RxMonitor matches recalls, and how often it fails
Source: Health Canada — Recalls and Safety Alerts. Data current as of 2026-08-12. Matched on product name, not on DIN — the feed carries none.